[Antitumor cellular immunotherapy: the breakthrough of dendritic cells]

The next generation of antibody-drug conjugates.

Nature medicine·2026

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.

ESMO open·2026

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors.

ESMO open·2026

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Genomic determinants of response to alpelisib plus fulvestrant in the SOLAR-1 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer.

ESMO open·2026

[Gynecological cancer surgery: Is robotic surgery an advantage over conventional laparoscopy?]

Bulletin du cancer·2026

[Management of chronic pulmonary GVH in 2025, indication for lung transplantation (SFGM-TC)].

Bulletin du cancer·2026

[Guidelines for the essential data entry in the European Bone Marrow Transplant Registry].

Bulletin du cancer·2026

[Sexual and reproductive life of men and women with chronic myeloid leukemia: Opinion and practical considerations of the Fi-LMC group].

Bulletin du cancer·2026

[Transoral robotic surgery in head and neck cancers].

Bulletin du cancer·2026

[Who refer patients with multiple myeloma to hematology-oncology: A retrospective study at Hôtel-Dieu de France].

Bulletin du cancer·2026

Binding specificity of IgG antibodies to mycobacterial DNA in plasmas of patients with tuberculosis and healthy controls.

ImmunoHorizons·2026

Age-related changes in the human T cell receptor alpha repertoire suggest positive selection of dual-specific T cells.

Journal of immunology (Baltimore, Md. : 1950)·2026

Clinical and endoscopic features of checkpoint inhibitor-induced colitis and their association with selective immunosuppressive therapy use.

Inflammatory bowel diseases·2026

Vaccine Ligand Binding Assay Development.

Bioanalysis·2026

Immunohistochemistry Assay Based on Ready-To-Use Antibodies and Vendor-Recommended Protocol Settings Often Perform Suboptimally.

Applied immunohistochemistry & molecular morphology : AIMM·2026

Gene-edited hypoimmune islets as a cure for type 1 diabetes: a review of the immunological challenges.

Expert opinion on biological therapy·2026

Related Experiment Videos

[Antitumor cellular immunotherapy: the breakthrough of dendritic cells]

Related Concept Videos

The next generation of antibody-drug conjugates.

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Genomic determinants of response to alpelisib plus fulvestrant in the SOLAR-1 trial.

Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer.

[Gynecological cancer surgery: Is robotic surgery an advantage over conventional laparoscopy?]

[Management of chronic pulmonary GVH in 2025, indication for lung transplantation (SFGM-TC)].

[Guidelines for the essential data entry in the European Bone Marrow Transplant Registry].

[Sexual and reproductive life of men and women with chronic myeloid leukemia: Opinion and practical considerations of the Fi-LMC group].

[Transoral robotic surgery in head and neck cancers].

[Who refer patients with multiple myeloma to hematology-oncology: A retrospective study at Hôtel-Dieu de France].

Binding specificity of IgG antibodies to mycobacterial DNA in plasmas of patients with tuberculosis and healthy controls.

Age-related changes in the human T cell receptor alpha repertoire suggest positive selection of dual-specific T cells.

Clinical and endoscopic features of checkpoint inhibitor-induced colitis and their association with selective immunosuppressive therapy use.

Vaccine Ligand Binding Assay Development.

Immunohistochemistry Assay Based on Ready-To-Use Antibodies and Vendor-Recommended Protocol Settings Often Perform Suboptimally.

Gene-edited hypoimmune islets as a cure for type 1 diabetes: a review of the immunological challenges.

Related Experiment Videos

[Antitumor cellular immunotherapy: the breakthrough of dendritic cells]

Related Concept Videos

Related Articles